Delivery Order HHSN268201600033I-75N92019F00074
Award Date 9/25/19
Potential Completion Date 9/24/22
Potential Value $3.1M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
5
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order under the Centralized Omic REsource for TOPMed (CORE) indefinite delivery contract, awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Baylor College of Medicine, a private health sciences university in Houston, Texas. The contract, valued at $4,007,254.53, is for the third year of the Centralized Omics Resource (CORE) program, which supports biomedical research and development activities. The...
- This is a Definitive Contract awarded by the National Heart Lung and Blood Institute, a component of the U.S. Department of Health and Human Services, to Baylor College of Medicine, a private health sciences university in Houston, Texas. The contract is for "SPECIAL STUDIES/ANALYSIS- OTHER" services with a Firm Fixed Price pricing structure and a ceiling value of $20,267,345.66. The contract was awarded on September 25, 2015, with an ultimate completion date of September 24, 2017....
- The National Heart, Lung and Blood Institute issued a delivery order to University of Washington on September 25, 2020, under the Centralized Omics Resource for TOPMed (CORE) parent vehicle with a ceiling value of $12.8 million and an ultimate completion date of June 30, 2027. CORE is a research infrastructure vehicle supporting centralized omics analysis and data services for TOPMed and related biomedical research initiatives across National Institutes of Health funding. Place of performance is...
- The National Institutes of Health National Heart, Lung and Blood Institute awarded a $22.4 million firm fixed price delivery order to The Broad Institute, Inc. under the Centralized Omic REsource for TOPMed (CORE) multiple award IDIQ. The Broad Institute will provide sequencing services to support the Trans-Omics for Precision Medicine program. As a non-profit research organization partnering with universities and medical centers, The Broad Institute leverages over $500 million in federal...
- The National Heart, Lung and Blood Institute issued a $3.63 million delivery order to The Broad Institute, Inc. on September 28, 2023, for the Trans-Omics for Precision Medicine (TOPMed) Centralized Omics Resource (CORE) Task Areas 2, 3, and 4, with an ultimate completion date of September 27, 2027. The order is issued under a single-award indefinite delivery contract with NHLBI for the TOPMed initiative. Place of performance is Cambridge, MA. The order carries firm fixed price terms and no...
- This is a $5,400 firm-fixed-price purchase order contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services, to Baylor College of Medicine, a private university and non-profit organization located in Houston, Texas. The contract does not have a set-aside designation. Baylor College of Medicine is a leading academic medical center known for its expertise in areas such as genomics,...
- The National Heart Lung and Blood Institute issued a $24.9 million delivery order to The Broad Institute, Inc. on September 23, 2024, for Trans-Omics for Precision Medicine (TOPMed) Centralized Omics Resource (CORE) Task Areas 2, 3, and 4, with completion by September 22, 2027. This delivery order is issued under the single-award indefinite delivery contract with NHLBI for the TOPMed initiative, which provides genomic sequencing, analysis, and data management infrastructure supporting...
- This is a firm fixed-price delivery order awarded by the Department of Transportation Federal Aviation Administration Franchise Acquisition Services to Baylor College of Medicine, a private non-profit university, for $176,529.50. The contract is for nucleic acid sequencing services to be performed in Oklahoma City, Oklahoma. The contract does not have a set-aside designation. Baylor College of Medicine is a health sciences university that conducts biomedical research and provides related goods...
- The National Heart, Lung and Blood Institute issued a $23.4 million delivery order to The Broad Institute, Inc. on September 26, 2025, for continued support of the Trans-Omics for Precision Medicine (TOPMed) Centralized Omics Resource (CORE). This delivery order is issued under the NHLBI's $500 million single-award indefinite delivery contract with the Broad Institute for the TOPMed initiative. Place of performance is Cambridge, MA. The order carries a ceiling value of $23,370,908.70 and an...
- This is a firm fixed-price delivery order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Heart, Lung and Blood Institute to the University of Washington. The $2,990,000 delivery order is for DNA Methylation services as part of the Centralized Omics Resource (CORE) indefinite delivery contract, which has a potential value of $500,000,000 over 10 years from September 2023 to September 2033. The CORE contract is to provide centralized omics...
- Centralized Omic REsource for TOPMed (CORE)Master IDIQ
- HHSN268201600033IIndefinite Delivery Contract
- HHSN268201600033I-75N92019F00074Delivery Order
Baylor College of Medicine was awarded a $3.1 million delivery order against the Centralized Omic REsource for TOPMed (CORE) master IDIQ by the National Heart, Lung and Blood Institute. The firm fixed price order is for the fourth year of the CENTRALIZED OMICS RESOURCE (CORE) program, a National Institutes of Health effort to establish centralized resources to support large-scale genomic studies. Performance will take place in Bethesda, Maryland over a three-year period concluding in September 2022. No subcontractors or set aside designations were indicated.
Generated 12/29/23, 9:59 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Close Out | ($8k) | 12/28/23 | |
| P00002 | Other Administrative Action | $0 | 9/17/21 | |
| P00001 | Other Administrative Action | $0 | 9/16/20 | |
| Not listed | Not listed | $3.1m | 9/25/19 |